PropertyValue
?:abstract
  • Headache occurs in only about 13% of patients within the cohort of presenting COVID-19 symptoms. The hypothesis that such a painful symptomatic picture could be considered a prognostic factor for COVID-19 positive evolution or its trend of severity, or the co-generation of hyposmia/anosmia and/or hypogeusia/ageusia, needs robust epidemiological data, punctual pathophysiological demonstrations, and a detailed comparative analysis on drug–drug interactions (DDIs).
is ?:annotates of
?:creator
?:doi
?:doi
  • 10.1007/s42399-020-00657-7
?:journal
  • SN_Compr_Clin_Med
?:license
  • cc-by
?:pdf_json_files
  • document_parses/pdf_json/cd520afa35efc660d1175e007464f266e9943316.json
?:pmc_json_files
  • document_parses/pmc_json/PMC7690334.xml.json
?:pmcid
?:pmid
?:pmid
  • 33263101.0
?:publication_isRelatedTo_Disease
?:sha_id
?:source
  • Medline; PMC
?:title
  • Headache as a Prognostic Factor for COVID-19. Time to Re-evaluate
?:type
?:year
  • 2020-11-26

Metadata

Anon_0  
expand all